TABLE 2.
Review of studies investigating effect of AF burden on mortality
First Author, year | N | Data Source | AF Burden Definition | Outcome |
---|---|---|---|---|
Disertori,11 2013 | 1234 | GISSI study | Clinical classification of AF | No difference in mortality with persistent vs. paroxysmal AF (HR 0.52, CI 0.13-2.03, p = 0.35) |
Steinberg,12 2015 | 14264 | ROCKET-AF study | Clinical classification of AF | Increased all-cause mortality with persistent vs. paroxysmal AF (HR 1.27, CI 1.06-1.49, p = 0.006) |
Link,13 2017 | 21105 | ENGAGE AF-TIMI 48 study | Clinical classification of AF | Increased all-cause mortality with persistent vs. paroxysmal AF (HR 1.37, CI 1.20-1.56, p < 0.001), and permanent vs. paroxysmal AF (HR 1.28, CI 1.15-1.45, p < 0.001) |
Lip,15 2008 | 7329 | SPORTIF III and V studies | Clinical classification of AF | No difference in mortality with paroxysmal vs. persistent AF (HR 1.24, CI 0.87-1.76, p = 0.24) |
Chew,18 2022 | 39710 | CIED data from Merlin.net remote monitoring database | Daily percent time in AF | Increased all-cause mortality with each 10% increase in daily AF burden (HR 1.061 per 10% increase, CI 1.045-1.076, p < 0.001) |
Park,24 2021 | 496 | Single center remote monitoring data | Total time spent in AF during follow up interval | Increased odds of composite outcome (progression to clinical AF, ischemic stroke, MI, HF-related hospitalization, or cardiac death) with high-burden SCAF (≥24 hours in 6 months) (OR 20.1, CI 7.6-52.7, p < 0.001) |
Piccini,25 2019 | 3131 | CIED data from Merlin.net remote monitoring database | Time in AF in one week | Increased odds of death with increase in weekly AF burden > 6h (OR 2.30, CI 2.09-2.53, p < 0.001) |
AF = atrial fibrillation, CIED = cardiac implantable electronic device, HF = heart failure, MI = myocardial infarction, SCAF = subclinical atrial fibrillation, TE = thromboembolism